BeOne Medicines Ltd.
ONC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651308
In the last 90 days, BeOne Medicines Ltd. insiders filed 0 open-market purchases and 16 sales; 283 institutions reported holding it in 13F filings for Q2 2026, worth $9.93B in total; no superinvestor holds it.
Other share classesBEIGF
Q3 2023 vs. Q2 2023
How the institutions holding BeOne Medicines Ltd. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 209 | 2 | 201 | −6 |
| Shares | 47.1M | 146.0K | 47.3M | +355.6K (+0.8%) |
| Value | $8.39B | $26.0M | $8.46B | +$91.3M (+1.1%) |
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held BeOne Medicines Ltd. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pictet Asset Management Holding SA | 128,962 | $23.2M | 0.03% |
| Jefferies Financial Group Inc. | 46,000 | $8.27M | 0.21% |
| Ovata Capital Management Ltd | 22,701 | $4.05M | 5.09% |
| LMR Partners LLP | 13,881 | $2.50M | 0.06% |
| Capricorn Fund Managers Ltd | 13,735 | $2.47M | 0.86% |
| Walleye Capital LLC | 7,788 | $1.40M | 0.02% |
| Y-Intercept (Hong Kong) Ltd | 3,587 | $645.2K | 0.06% |
| Nine Masts Capital Ltd | 3,077 | $549.7K | 0.40% |
| Qtron Investments LLC | 1,674 | $301.1K | 0.06% |
| Tudor Investment Corp Et Al | 1,600 | $287.8K | 0.00% |
| Vident Advisory, LLC | 1,442 | $259.4K | 0.01% |
| Cetera Advisor Networks LLC | 1,234 | $222.0K | 0.00% |
| Truist Financial Corp | 1,128 | $202.9K | 0.00% |
| Walleye Trading LLC | 224 | $40.3K | 0.00% |
| Steward Financial Group LLC | 35 | $6.00K | 0.00% |
| Whittier Trust Co | 26 | $4.68K | 0.00% |
| FinTrust Capital Advisors, LLC | 6 | $1.14K | 0.00% |
| Brown Brothers Harriman & Co | 6 | $1.08K | 0.00% |
| Federation des caisses Desjardins du Quebec | 5 | $899 | 0.00% |
| Macroview Investment Management LLC | 3 | $540 | 0.00% |
Sold out (26)
Institutions that held BeOne Medicines Ltd. at the end of Q2 2023 and filed for Q3 2023 without it.
Not filed for Q3 2023 yet (2)
Institutions that held BeOne Medicines Ltd. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Pictet Asset Management SA | 125,054 | $22.3M |
| Tekla Capital Management LLC | 20,952 | $3.74M |